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The purpose of this study was to evaluate the growth patterns and osteogenic differentiation of human bone
marrow mesenchymal stem cells (hBMSCs) when seeded onto new biodegradable chitosan/polyester scaffolds.
Scaffolds were obtained by melt blending chitosan with poly(butylene succinate) in a proportion of 50% (wt)
each and further used to produce a fiber mesh scaffold. hBMSCs were seeded on those structures and cultured for
3 weeks under osteogenic conditions. Cells were able to reduce MTS and demonstrated increasing metabolic
rates over time. SEM observations showed cell colonization at the surface as well as within the scaffolds. The
presence of mineralized extracellular matrix (ECM) was successfully demonstrated by peaks corresponding to
calcium and phosphorus elements detected in the EDS analysis. A further confirmation was obtained when carbonate
and phosphate group peaks were identified in Fourier Transformed Infrared (FTIR) spectra. Moreover, by reverse
transcriptase (RT)-PCR analysis, it was observed the expression of osteogenic gene markers, namely, Runt related
transcription factor 2 (Runx2), type 1 collagen, bone sialoprotein (BSP), and osteocalcin. Chitosan-PBS (Ch-
PBS) biodegradable scaffolds support the proliferation and osteogenic differentiation of hBMSCs cultured at
their surface in vitro, enabling future in vivo testing for the development of bone tissue engineering therapies.
Introduction
Mesenchymal stem cells (MSCs) isolated from bone marrow
stroma have the capacity to differentiate into cells of connective
tissues, namely, into osteoblasts, chondrocytes, and adipocytes.1-4
However, recent studies,5 indicate that they may have a much
broader differentiation potential. Accordingly, the multipotential
capacity of MSCs, their accessible origin, high ex vivo expansive
potential, and ethical acceptance, make these cells attractive tools
for tissue engineering and cell-based therapies.
Annually, more than 2.2 million bone grafting procedures
(autologous bone graft and banked bone) are performed
worldwide to ensure adequate bone healing in many skeletal
problems, such as nonunion fractures, cervical and lumbar spine
fusion, joint arthrodesis, and revision arthroplasty.6 Unfortu-
nately, the gold standard of bone grafting (autologous bone)
requires an extra surgery to retrieve it from the patient. This
leads to an increase in surgical and recovery times. Potential
complications, such as chronic pain at the donor site, infections,
and eventual disability7 can occur. Tissue engineering offers a
strategy to circumvent those problems. The concept involves
the use of a porous and biodegradable scaffold, allowing cells
to adhere and proliferate, creating conditions for the formation
of ECM-like structures.8-10 Previous studies have shown that
natural based polymers such as starch11-18 or chitosan19-36 have
great potential for bone tissue engineering applications. The
main advantages of these materials include low immunogenic
potential, bioactive behavior, good interaction with host tissues,
chemical versatility, and high availability in nature.7
Chitosan has already shown a range of properties, including
its nonantigenicity33 and cytocompatibility,35,36 that suggest
having adequate properties for bone tissue engineering applica-
tions. However, the material offers limited versatility in its
processability. To overcome this problem, we propose a novel
methodology to process chitosan by compounding this material
with biodegradable aliphatic polyesters.23 The blend combines
the favorable biological properties of chitosan with the good
mechanical properties and processability of polyesters,23-30
leading to a chitosan based material with adjustable properties
for tissue engineering applications.27-30
The purpose of the present work is to evaluate the perfor-
mance of the developed microfiber mesh scaffolds. For that,
we assess the cell adhesion, proliferation, and osteogenic
differentiation of human MSCs isolated from bone marrow and
seeded onto novel chitosan/polyester microfiber mesh scaffolds
aimed to be used in bone tissue engineering field.
Materials and Methods
Scaffold Processing. New chitosan based scaffolds were, developed
by a fiber bonding technique. The processing methodology is entirely
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melt based, thus avoiding the limitations of solvent-based processing,
and it is described in detail elsewhere.23 Briefly, chitosan was melt
blended with polybutylene succinate (PBS; 50/50 wt %) in a twin-
screw extruder. The extrudate was grinded into powder and further
processed into microfibers, using a microextruder. The diameter of the
fibers was controlled by the diameter of the die. After that, Ch-PBS
fibers were cut and submitted to hot compression. This last step15
consisted in applying temperature and pressure to obtain a fiber mesh
scaffold with inherent porosity and interconnectivity.
The scaffolds were sterilized by ethylene oxide and used for cell
culture studies.
Scaffolds Characterization. Chitosan-based fiber mesh scaffolds
were analyzed using a high-resolution microcomputed tomography
Skyscan 1072 scanner (Skyscan, Kontich, Belgium). Five scaffolds were
scanned in high resolution mode using a pixel size of 8.24 µm and
integration time of 2.0 ms. The X-ray source was set at 80 keV of
energy and 124 µA of current. For all the scanned specimens
representative data sets of 150 slices were transformed into binary using
a dynamic threshold of 60-255 (gray values) to distinguish polymer
material from pore voids. This data was used for morphometric analysis
(CT Analyzer v1.5.1.5, SkyScan). The morphometric analysis included
porosity, scaffolds interconnectivity and mean pore size quantifica-
tion. Three dimensional (3D) virtual models of representative regions
in the bulk of the scaffolds were also created, visualized and
registered using the image processing software (ANT 3D creator
v2.4, SkyScan).
The mechanical properties of the scaffolds were tested on compres-
sion tests carried out in a universal tensile testing machine (Instron
4505, Universal Machine). A crosshead speed of 5 mm/min was used
and the compression modulus was determined from the most linear
region of the stress-strain curve and averaged from the results obtained
with five specimens.
Cell Culture Studies. In Vitro Cytotoxicity Tests. A rat lung
fibroblast cell line-L929, acquired from the European Collection of Cell
Cultures (ECACC), was used for the initial standard cytotoxicity assays.
Tests were carried out following the international standard ISO 10993.
The procedure and methods are described elsewhere.19
hBMSCs Seeding and Culture onto the Scaffolds. Primary cultures
of hBMSCs were used. The cells were characterized by flow cytometry
for MSCs markers (CD31, CD34, CD45-negative and CD13, CD29,
CD73, CD90, CD105, CD166-positive cells) and differentiation studies
into osteogenic, chondrogenic, and adipogenic lineage.37 The cells were
grown in a culture medium consisting of alpha medium (Sigma, St.
Louis, MO), 10% fetal bovine serum (Biochrom AG, Germany), 5 mM
L-glutamine (Sigma, St. Louis, MO), 1 ng/mL basic fibroblast growth
factor (bFgF; PeproTech, U.S.A.), and 1% of antibiotic-antimycotic
mixture (Sigma, St. Louis, MO). When an adequate cell number was
obtained, cells at passage 2 were detached with trypsin/EDTA. Cells
were seeded at a density of 2.5 × 105 cells/scaffold under static
conditions, by means of a cell suspension. After 24 h of attachment,
cell-constructs were placed in new 24-well plates and 1 mL of
osteogenic medium was added to each well. The osteogenic culture
medium consisted of DMEM without phenol red, dexamethasone 10-8
M (Sigma, St. Louis, MO), ascorbic acid 50 µg/mL (Sigma, St. Louis,
MO), and !-glycerophosphate 10 mM (Sigma, St. Louis, MO). The
cell-constructs were cultured for periods of up to 7, 14, and 21 days in
a humidified atmosphere at 37 °C, containing 5% CO2.
The culture medium was changed every 2-3 days until the end of
the experiment.
Cellular Viability Assay: MTS Test. Cell viability was assessed after
3 h, 7, 14, and 21 days, using the MTS test. The cell-constructs (n )
3) were rinsed three times in phosphate-buffered saline (Sigma, St.
Louis, MO) and immersed in a mixture consisting of serum-free cell
culture medium and MTS reagent in a 5:1 ratio and incubated for 3 h
at 37 °C in a humidified atmosphere containing 5% CO2. After this,
200 µL (n) 3) were transferred to 96-well plates and the optical density
(O.D.) was measured on a microplate ELISA reader (BioTek, U.S.A.)
using an absorbance of 490 nm.
Cell Adhesion and Cell Viability Stained with Calcein-AM Using
Confocal Laser Microscopy. Cells were incubated with calcein AM
(Molecular Probes, Invitrogen, U.S.A.). Inside the cells, calcein-AM
is hydrolyzed by endogenous esterases into the highly negatively
charged green fluorescent calcein, which is retained inside the
cytoplasm. The cell-constructs were sectioned and cell adhesion,
proliferation, and viability were observed in the inner regions of the
scaffolds using an Olympus FluoView FV1000 confocal laser scanning
microscope.
Cell Adhesion and Morphology by Scanning Electron Microscopy
(SEM). Cell adhesion, morphology, and spatial distribution were
observed by SEM. Cell-constructs were washed in 0.15 M phosphate
buffered saline and fixed in 2.5% glutaraldehyde. After that, the
constructs were dehydrated using a graded series of ethanol (30, 50,
70, 90, 100%) for 15 min, twice. Then, the samples were immersed in
hexamethyldisilazane38 (HDMS; Electron Microscopy Sciences, Wash-
ington, U.S.A.) and allowed to air-dry for 2 h. Afterward, the constructs
were sputter coated with gold (JEOL JFC-1100) and analyzed using a
Leica Cambridge S360 scanning electron microscope.
Cell Proliferation by DNA Quantification. hBMSCs proliferation on
the Ch-PBS scaffolds was determined using a fluorimetric dsDNA
quantification kit (PicoGreen, Molecular Probes, Invitrogen, USA).
Samples collected at days 7, 14, and 21 were washed twice with a
sterile phosphate buffered saline solution and transferred into 1.5 mL
microtubes containing 1 mL of ultrapure water. Cell-constructs were
cryopreserved at -80 °C for further analysis. Prior to DNA quantifica-
tion, samples were thawed and sonicated for 15 min. Standards were
prepared with concentrations ranging between 0 and 2 mg/mL. Per each
well of an opaque 96-well plate were added 28.7 µL of sample (n )
3) or standard, 71.3 µL of PicoGreen solution, and 100 µL of Tris-
EDTA buffer. The plate was incubated for 10 min in the dark and
fluorescence was measured using an excitation wavelength of 480 nm
and an emission wavelength of 528 nm.
Alkaline Phosphatase Quantification. Samples were collected as
previously described. Alkaline phosphatase (ALP) activity of the
scaffold/cell-constructs (n) 3) was measured by the specific conversion
of p-nitrophenyl phosphate (pNpp) (Sigma, St. Louis, MO) into
p-nitrophenol (pNp). The cell-constructs were thawed at room tem-
perature and sonicated for 15 min. The enzymatic reaction was set up
by mixing 100 mL of the sample with 300 mL of substrate buffer
containing 1 M diethanolamine HCl (pH 9.8) and 2 mg/mL of pNpp.
The solution was further incubated at 37 °C for 1 h and the reaction
was stopped by the addition of a solution containing 2 M NaOH and
0.2 mM EDTA in distilled water. The O.D. was determined at 405
nm. A standard curve was made using pNp values ranging from 0 to
20 µmol/mL. The results were normalized by DNA values and
expressed in µmol of pNp produced/µg ds DNA. A detailed description
of the assay can be found elsewhere.39
Mineralization Content by Energy DispersiVe Spectroscopy
(EDS). The constructs were processed as described previously for SEM.
The samples (n ) 3) were sputter coated with carbon (JEOL JFC-
1100) with the purpose of analyzing the presence of Ca and P elements
at the surface by EDS with a Leica Cambridge S360 scanning electron
microscope. Sputter coating with carbon avoids overlapping of signals
of the coating with the elements being analyzed.
Mineralization Crystallinity by Fourier Transform Infra-Red
Spectroscopy (FTIR). The cell-constructs were washed in phosphate
buffered saline and fixed in 2.5% glutaraldehyde.
The samples were pressed into pellets with potassium bromide (KBr;
Riedel-de Haen, Germany). The IR spectrum was measured using a
FTIR spectrometer (model IRPrestige-21, Shimadzu; Germany) in the
wavelength range of 4000-400 cm-1.
Osteogenic Differentiation by ReVerse Transcriptase PCR. Total
RNA was isolated from cells with Trizol (Sigma, St Louis, U.S.A.),
according to the manufacturer protocol. A NanoDrop Microspectro-
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photometer (NanoDrop ND-1000 Spectrophotometer, Alfagene, U.S.A.)
was used to measure the total RNA amounts (ng/µL).
Aliquots of the total RNA (100 ng/µL) were transcripted into cDNA
and amplified in each PCR in one step RT-PCR beads (Amersham
Biosciences) and gene specific primers were added.
Each cDNA sample was run in triplicate for every PCR. Amplifica-
tion was performed using a Mastercycler gradient (MyCycler, Thermal
Cycler, Biorad). The first reverse transcription step at 42 °C for 30
min was followed by a step of denaturation at 95 °C during 5 min.
After this, 35 cycles of PCR were performed, each consisting of a
denaturation stage at 95 °C for 1 min, annealing at a given temperature
accordingly with the specific primer used, and then an extension stage
at 72 °C for 2 min. In all cases, a final extension at 72 °C for 5 min
was performed before storing the samples at 4 °C. Specific primers
used were for human Runx2, osteocalcin, type 1 collagen, BSP and
for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
PCR products were separated by 1% agarose (Biorad, U.S.A.) at
least twice. The separated DNA fragments were visualized by ethidium
bromide (Sigma, St Louis, MO) staining and observed with an Eagleye
software (Alpha Innotech, U.S.A.) using excitation at 514 nm and
emission at 610 nm.
Statistical Analysis. Results of MTS and ALP are expressed as mean
( standard deviation with n ) 3 for each group. Statistical significance
of differences was determined using Student’s t-test multiple comparison
procedure at a confidence interval of 95% (p < 0.05).
Results
Scaffolds Characterization. Porous chitosan-based fiber
mesh scaffolds used in this study were produced with a blend
of 50% chitosan and 50% poly(butylene succinate). The
scaffolds were prepared using melt extrusion, followed by hot
compression (fiber bonding). Scaffolds were cut into cylinders
of approximately 6.5 mm diameter and thickness of 1.5 mm.
Figure 1 shows the top surface of the novel chitosan based fiber
mesh scaffold produced by the described melt based process.
Scaffolds show a large porosity and inherent interconnectivity,
as well as an irregular distribution of the fiber orientation as
intended.
The µ-CT technology allows obtaining series of X-ray slice
images covering a representative volume region of the porous
scaffold. The solid volume representation and the quantitative
data is obtained following image processing using specific
software and the X-rays micrographs obtained in each slice.
This technique was used to obtain 3D images of the novel
chitosan fiber mesh scaffolds (Figure 1a) and to quantitatively
determine the average porosity (44.8% ( 2.1) and the inter-
connectivity of 89.6%( 1.9. Compression mechanical tests have
shown that scaffolds have a compression modulus of 32.6 (
12.8 MPa, which is within the range of interest for bone
applications.40
The fibers used to produce these scaffolds have an average
diameter of 450 µm and as can be seen in Figure 1b, evidence
an interesting surface roughness that may contribute to enhance
the cell adhesion by increasing the surface area. Moreover,
detailed observations using µ-CT equipment show that microfi-
bers in addition to the surface roughness also possess some
microporosity at the surface that further enhances the surface
area (Figure 1a).
In Vitro Cytotoxicity Tests. In the MTS test (data not
shown), L929 fibroblasts metabolized MTS into brown formazan
product after incubation with the scaffold’s extract. This fact
evidences that the cells have metabolic activities (around 80%)
similar to those obtained by cells grown in DMEM (negative
control). Moreover, they were able to incorporate and metabolize
MTS, showing very high viability. Therefore, the leachables
released from the tested scaffolds can be considered as
noncytotoxic.
Cell Viability by MTS and Calcein-AM Staining. Results
showed that the tested hBMSCs were also able to reduce MTS
(Figure 2), demonstrate high metabolic rates as a function of
time, and denote a high viability and proliferation profile.
Moreover, a cell viability assay with calcein-AM staining
(Figure 3) demonstrated that hBMSCs were metabolically active
and well distributed throughout the scaffold surfaces after 3
weeks.
Cell Adhesion and Morphology by SEM. After 1 week,
hBMSCs cultured under osteogenic conditions, were able to
adhere to the fibrous surface and inner pores of the scaffolds
and to proliferate during the subsequent periods in culture
(Figure 4A,D,G). The production of ECM can be analyzed in
more depth at higher magnifications (Figure 4C,F,I). Further-
more, it is observed that the cells were able to create “bridges”
between neighboring fibers, but without occluding the pores
(Figure 4B,E). Cells were also capable of colonizing the inner
regions of the scaffolds, keeping the viability on those inner
pores (Figure 4J,K,L).
Alkaline Phosphatase Quantification. The expression of
ALP is typically used as an early marker of the osteogenic
phenotype. The ALP expression shows the typical pattern of
expression (Figure 5) increasing until the second week, where
it reached its maximum. This observation reflects the early
osteogenic differentiation stage of the MSCs. After this period,
ALP activity decreased, probably due to the onset of the
mineralization process.39 This observation is a positive indication
of the transient character of the differentiation of cells into the
osteogenic lineage.
Mineralization Content of ECM by EDS and FTIR
Analysis. EDS analysis of the surface of cell-constructs detected
the presence of Ca and P elements (Figure 6A). Acellular
scaffolds (control) do not show any presence of those two
Figure 1. 3D images obtained by µ-CT reconstruction model (a) and SEM photomicrograph of Ch-PBS (50 wt %) fiber mesh scaffold (b).
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elements during the same period of immersion in osteogenic
inducing culture medium. These results clearly indicate the
formation of mineralized ECM at the surface of cell seeded
scaffolds. These results were further confirmed by FTIR analysis
(Figure 6C), showing the presence of phosphate and carbonate
groups, which are typical for carbonated apatite.41
Osteogenic Differentiation of hMSCs upon Chitosan-Based
Scaffolds. To further analyze the differentiation toward the
osteogenic phenotype, the RNA of the cell cultured in the
scaffolds is analyzed by reverse transcriptase PCR (Figure 7).
PCR analysis shows the expression of specific genes related
to the osteogenic lineage, namely, the transcription factor Runx2,
considered to be a crucial transcription gene within the osteo-
genic phenotype.42,43 Its expression was detected at all time
points, being more pronounced at the third week of culture. The
gene expression patterns of the various extracellular proteins,
including osteocalcin, type 1 collagen, and BSP, was detected
at all time points and in increased levels at the latest time point.
This indicates a successful differentiation into the osteogenic
phenotype.
Discussion
The demand for new therapies for diseases affecting mus-
culoskeletal tissues is continuously increasing, especially con-
sidering the high number of patients suffering from skeletal
degenerative diseases. Bone tissue engineering has been propos-
ing solutions to address those clinical problems. The strategy
could combine cells with a 3D scaffold and growth factors,
seeking to achieve the regeneration of bone tissue.
Natural-based polymers such as chitosan, a polymer produced
by partial deacetylation of chitin, have been proposed as having
potential for tissue engineering applications. Chitosan is char-
acterized by its good biocompatibility, low immunogeneicity,
noncytotoxicity and wound healing capability. These properties
make chitosan a strong candidate material for bone tissue
engineering applications. Due to its limited mechanical proper-
ties and process ability, scaffolds produced only with chitosan
are more difficult to optimize for hard tissue applications. An
alternative methodology to overcome those limitations consists
in blending chitosan with synthetic and biodegradable aliphatic
polyesters.23,30 Thermoplastic biodegradable polymers have
already shown great potential in the clinic as implantable
biomaterials due to their reported noncytotoxicity and biode-
gradability. Their degradation products are also noncytotoxic,
although they lack the cell recognition affinity typically provided
by natural polymers. Thus, by blending chitosan with synthetic
polyesters, it is possible to obtain a good balance between
biological affinity27-29 and processability, not compromising
the biodegradability.
The developed fibrous scaffolds showed a significant inter-
connectivity (Figure 1), which is known to be a critical condition
for successful cell colonization and viability. Extracts from the
developed scaffolds are noncytotoxic in contact with L929 cells
(data not presented herein).
Human MSCs showed high metabolic levels when adhered
onto the scaffolds both by the reduction of the MTS substrate
(Figure 2) and also by the calcein-am staining (Figure 3).
SEM micrographs (Figure 4) show that hBMSCs adhered at
the surface of the scaffolds and were able to “bridge” between
fibers without occluding the pores (Figure 4C). The proliferation
of hBMSCs and the production of ECM showed increased levels
over time (Figure 4A,D,G). SEM observations and cell viability
results can help to establish a time-dependent cell proliferation
pattern as showing the presence of higher number of cells at
late time periods. It was also observed that cells proliferated
Figure 2. MTS viability assay of cell-constructs and cultured Ch-PBS scaffolds following 3 h (0 days), 7, 14, and 21 days after cell seeding.
Results are expressed as means ( standard deviation with n ) 3 for each bar; (*) indicates a significant difference (p < 0.05) between testing
conditions as a function of time.
Figure 3. Cell viability after three weeks of cell-culture in the scaffolds
analyzed by calcein-AM staining. Confocal micrograph showing cell
adhesion and viability on the Ch-PBS fiber mesh scaffolds after 3
weeks in culture.
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and colonized the inner regions (Figure 4J-L) of the scaffolds,
which demonstrate that porosity and interconnectivity exhibited
by the scaffolds are adequate for cell infiltration and ingrowth.
ALP activity measurements (Figure 5) showed a maximum
at the second week of culture, reflecting the early osteogenic
differentiation stage of hMSCs.39 After this period, ALP activity
decreased due to the onset of the mineralization process, which
is a typical positive indication.
hBMSCs were able to produce mineralized ECM confirmed
by the presence of Ca and P elements (Figure 6a). Furthermore,
Figure 4. SEM micrographs of the adhesion and proliferation of hBMSCs, under osteogenic induction, on the 50% wt Ch-PBS fiber mesh
scaffolds at the surface after 1 week (A, B, C), 2 weeks (D, E, F), and 3 weeks (G, H, I). The micrographs J, K, and L correspond to cross
sections of the cell seeded scaffolds after 3 weeks, showing the bulk colonization by the cells.
Figure 5. Alkaline phosphatase activity of hBMSCs cultured on the scaffolds at time points 1, 2, and 3 weeks, under osteogenic induction. The
results are normalized by µg of dsDNA and presented in amount of p-nitrophenol (µmol/mL/h/µg dsDNA). Results are expressed as average (
standard deviation with n ) 3 for each bar, (*) indicates a significant difference (p < 0.05) between conditions as a function of time.
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the existence of characteristic peaks of carbonate and phosphate
groups in FTIR spectra (Figure 6C) indicates the presence of
carbonated apatite at the surface of cell-constructs.
The differentiation of the hBMSCs toward the osteogenic
lineage was ultimately demonstrated by the expression of genes
that are usually associated with the mineralization during
osteogenesis, such as the transcription factor Runx2, and the
matrix proteins osteocalcin, type 1 collagen, and BSP (Figure
7). Runx2 is essential for the differentiation of MSCs into mature
osteoblasts in the skeletal development of numerous mammalian
organisms.42,43 Osteocalcin, one of the few osteogenic specific
genes, is a bone matrix protein and is known to play an
important role in the differentiation of osteoblast progenitor cells,
with significant up-regulation observed both in matrix synthesis
and in the mineralization process.43 BSP is secreted, bind cell
surface integrin receptors, and regulate mineralization, and type I
collagen represents the majority of the organic part of bone
matrix.44
Conclusions
Chitosan-poly(butylene succinate) fiber mesh scaffolds were
successfully produced by a melt based routine, avoiding the use
of solvents. The scaffolds presented a high degree of intercon-
nectivity (89.6% ( 1.9) and adequate mechanical properties
(32.6 ( 12.8 MPa) for bone tissue engineering applications.
It was demonstrated that chitosan-PBS scaffolds are cyto-
compatible, both with L929 cells and hBMSCs. The scaffolds
support hBMSCs adhesion and proliferation under osteogenic
inducing conditions. The cells presented high levels of viability,
demonstrating that besides the remarkable colonization of the
scaffold structure, the cells were metabolically active.
ALP expression an mineralized ECM is detected by the
presence of Ca and P elements in EDS spectra and also
confirmed by FTIR. The expression of osteogenic related genes
(Runx2, osteocalcin, type 1 collagen and bone sialoprotein) show
successful differentiation of the cells in the scaffolds toward
an osteogenic phenotype.
Due to the extremely well balanced combination of properties
and excellent biological performance, it is strongly believed that
the scaffolds herein proposed in combination with human adult
mesenchymal stem cells will provide new therapies for the
development of tissue engineering solutions for bone
regeneration.
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